Careers
News
Contact Us
Who We Are
Who We Are
Our Culture
Company History
Leadership Team
What We Do
What We Do
Authorized Generics
Business Development
Sales
Commercialization Services
Products & Savings
Co-Pay Cards
Product List
Patient Assistance
Select Page
Launched 50th Authorized Generic
by
scalewp-dev
|
Jan 20, 2022
Launched 25th Authorized Generic
by
scalewp-dev
|
Jan 20, 2022
Grand opening of Prasco’s new corporate headquarters in Mason, OH
by
scalewp-dev
|
Jan 20, 2022
Launched first pharmaceutical product
by
scalewp-dev
|
Jan 20, 2022
Prasco expands portfolio through acquisition of first Cll product
by
scalewp-dev
|
Jan 20, 2022
« Older Entries
Next Entries »
Search for:
Recent Posts
Authorized Generic of Farxiga® (Dapagliflozin) Tablets and Xigduo® (Dapagliflozin/Metformin) Extended-Release Tablets Available from Prasco
Prasco Launches Authorized Generic of ZIOPTAN® Ophthalmic Solution
Prasco Launches the Authorized Generic of NuvaRing® (etonogestrel/ethinyl estradiol vaginal ring)
Prasco Launches the Authorized Generic of ADVAIR DISKUS® (fluticasone propionate and salmeterol inhalation powder)
Prasco Appoints VP of Trade Relations and New Chief Marketing Officer
Recent Comments
hello world
on
Authorized Generic of Farxiga® (Dapagliflozin) Tablets and Xigduo® (Dapagliflozin/Metformin) Extended-Release Tablets Available from Prasco
92stargamedownload
on
Federal Trade Commission Reports: Authorized Generics, during the 180-day Exclusivity Period, Benefit Consumers and the American Healthcare System
ls168game
on
Federal Trade Commission Reports: Authorized Generics, during the 180-day Exclusivity Period, Benefit Consumers and the American Healthcare System
ls168gamedownload
on
Federal Trade Commission Reports: Authorized Generics, during the 180-day Exclusivity Period, Benefit Consumers and the American Healthcare System
gamespkdownload
on
Prasco to Market Authorized Generic of ZEGERID®
Recent Comments